UC Receives $2 Million Gift to Benefit Pediatric Ophthalmology
The University of Cincinnati (UC) Academic Health Center has received a $2 million endowment to support research and education related to ophthalmic disorders of children.
The gift, from Ira A. Abrahamson Jr., MD, will establish the Ira A. Abrahamson, MD, Endowed Chair of Pediatric Ophthalmology (Abrahamson Chair) in UCs department of ophthalmology.
The Abrahamson Chair will be awarded to the director of the UC division of pediatric ophthalmology, who also will serve as director of pediatric ophthalmology at Cincinnati Childrens Hospital Medical Center.
The UCCincinnati Childrens programs work jointly in the diagnosis and treatment of retinoblastoma, the leading type of eye cancer in children.
The Abrahamson Chair will link UCs department of ophthalmology even more closely than before with the division of pediatric ophthalmology at Cincinnati Childrens, said James Augsburger, MD, chair of the UC ophthalmology department. Dr. Abrahamsons new gift will ensure continued expansion of pediatric ophthalmology at both institutions and improved eye care for all children in our region. We are thankful for Dr. Abrahamsons generosity and commitment.
Dr. Abrahamson is a 1948 graduate of UC College of Medicine and an emeritus faculty member in the ophthalmology department.
Funds from the Abrahamson endowment will be used within the UC pediatric ophthalmology division and at the Abrahamson Pediatric Eye Institute at Cincinnati Childrens, founded by Dr. Abrahamson in 1995.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.